Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kimberly L, Dinh"'
Effect of Exogenous Antithrombin Administration on Anti-Xa Levels in Infants Treated With Enoxaparin
Autor:
Jennifer L. Placencia, Brady S. Moffett, Kimberly L. Dinh, Danielle R. Rios, Emily Rodman, Brittany B. Logston
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 23:315-319
OBJECTIVES Determine the effect of exogenous antithrombin III administration on low molecular weight heparin anti-Xa levels in the context of enoxaparin dosing in infants. METHODS A retrospective chart review of infants receiving concomitant antithro
Autor:
Christopher J. Rhee, Brady S. Moffett, Kimberly L. Dinh, Jennifer L. Placencia, Danielle R. Rios, Mengwei Ni, Jeffrey R. Kaiser, Joseph Hagan
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 22:430-435
OBJECTIVE To evaluate the safety and efficacy of vasopressin for the treatment of hypotension in patients admitted to neonatal intensive care units (NICUs). METHODS Vasopressin use in 69 infants admitted to our NICU between 2011 and 2014 was examined
Autor:
Paul G. Steinkuller, David K. Coats, Lingkun Kong, Kimberly L. Dinh, Robert G. Voigt, Sid A. Schechet, Ann B. Demny
Publikováno v:
Ophthalmology Research: An International Journal. 3:13-22
Purpose: To compare vision and developmental outcomes in infants who were treated with intravitreal bevacizumab injection (IVB) versus laser for retinopathy of prematurity (ROP). Methods: Forty-two infants were enrolled in this study and treated with
Publikováno v:
Clinics in Perinatology. 41:347-361
Micronutrient requirements are well-established for healthy full-term infants. However, few such recommendations exist for high-risk infants, including full-term infants with a variety of medical disorders or very preterm infants. Key micronutrients
Autor:
Leanna K, Darland, Kimberly L, Dinh, Shelly, Kim, Jennifer L, Placencia, Nidhy P, Varghese, Fadel, Ruiz, George B, Mallory, Caraciolo J, Fernandes
Publikováno v:
Pediatric pulmonology. 52(2)
To compare the occurrence of hypotension following administration of intermittent intravenous (IV) and enteral sildenafil for treatment of pulmonary hypertension (PH) in infants. We hypothesized there may be more adverse effects associated with inter